These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25197640)

  • 41. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease.
    Chan AY; Baum L; Tang NL; Lau CY; Ng PW; Hui KF; Mizuno Y; Kwan JY; Mok VC; Kuo SH
    J Clin Neurosci; 2013 May; 20(5):761-2. PubMed ID: 23522931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATP13A2/PARK9 regulates secretion of exosomes and α-synuclein.
    Tsunemi T; Hamada K; Krainc D
    J Neurosci; 2014 Nov; 34(46):15281-7. PubMed ID: 25392495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
    Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
    Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
    Dos Santos AV; Pestana CP; Diniz KR; Campos M; Abdalla-Carvalho CB; de Rosso AL; Pereira JS; Nicaretta DH; de Carvalho WL; Dos Santos JM; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2010 Nov; 485(2):121-4. PubMed ID: 20816920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATP13A2 variants in early-onset Parkinson's disease patients and controls.
    Djarmati A; Hagenah J; Reetz K; Winkler S; Behrens MI; Pawlack H; Lohmann K; Ramirez A; Tadić V; Brüggemann N; Berg D; Siebner HR; Lang AE; Pramstaller PP; Binkofski F; Kostić VS; Volkmann J; Gasser T; Klein C
    Mov Disord; 2009 Oct; 24(14):2104-11. PubMed ID: 19705361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China.
    Fei QZ; Cao L; Xiao Q; Zhang T; Zheng L; Wang XJ; Wang G; Zhou HY; Wang Y; Chen SD
    Neurosci Lett; 2010 May; 475(2):61-3. PubMed ID: 20227461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.
    Usenovic M; Knight AL; Ray A; Wong V; Brown KR; Caldwell GA; Caldwell KA; Stagljar I; Krainc D
    Hum Mol Genet; 2012 Sep; 21(17):3785-94. PubMed ID: 22645275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice.
    Johnson ME; Bergkvist L; Stetzik L; Steiner JA; Meyerdirk L; Schulz E; Wolfrum E; Luk KC; Wesson DW; Krainc D; Brundin P
    Neurobiol Dis; 2021 Nov; 159():105513. PubMed ID: 34536552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset Parkinsonism.
    Guo JF; Xiao B; Liao B; Zhang XW; Nie LL; Zhang YH; Shen L; Jiang H; Xia K; Pan Q; Yan XX; Tang BS
    Mov Disord; 2008 Oct; 23(14):2074-9. PubMed ID: 18785233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations.
    Erro R; Picillo M; Manara R; Pellecchia MT; Barone P
    Parkinsonism Relat Disord; 2019 Aug; 65():272-273. PubMed ID: 31151786
    [No Abstract]   [Full Text] [Related]  

  • 53. A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier.
    Wöhlke A; Philipp U; Bock P; Beineke A; Lichtner P; Meitinger T; Distl O
    PLoS Genet; 2011 Oct; 7(10):e1002304. PubMed ID: 22022275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9).
    Eiberg H; Hansen L; Korbo L; Nielsen IM; Svenstrup K; Bech S; Pinborg LH; Friberg L; Hjermind LE; Olsen OR; Nielsen JE
    Clin Genet; 2012 Sep; 82(3):256-63. PubMed ID: 21696388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.
    Tan J; Zhang T; Jiang L; Chi J; Hu D; Pan Q; Wang D; Zhang Z
    J Biol Chem; 2011 Aug; 286(34):29654-62. PubMed ID: 21724849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease.
    Suleiman J; Hamwi N; El-Hattab AW
    Brain Dev; 2018 Oct; 40(9):824-826. PubMed ID: 29903538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autosomal recessive mutations in the development of Parkinson's disease.
    Lopez G; Sidransky E
    Biomark Med; 2010 Oct; 4(5):713-21. PubMed ID: 20945983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.
    Ramonet D; Podhajska A; Stafa K; Sonnay S; Trancikova A; Tsika E; Pletnikova O; Troncoso JC; Glauser L; Moore DJ
    Hum Mol Genet; 2012 Apr; 21(8):1725-43. PubMed ID: 22186024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.
    Vrijsen S; Besora-Casals L; van Veen S; Zielich J; Van den Haute C; Hamouda NN; Fischer C; Ghesquière B; Tournev I; Agostinis P; Baekelandt V; Eggermont J; Lambie E; Martin S; Vangheluwe P
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31198-31207. PubMed ID: 33229544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.